SecBot SecBot
PRESS-RELEASE ·Filed Nov 5, 2026

EVH

Evolent Health, Inc.
NEUTRAL
Impact 5/10
Horizonweeks Processed11d 17h ago WireGlobeNewswire
Press release · Earnings
Actionable Insight • Neutral

Revenue growth is strong but margin compression from rising medical costs is the key watch item. The raised EBITDA guidance suggests management sees some stabilization; monitor next quarter's medical expense ratio and any further guidance changes.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$4.54
T+0 close · Nov 5, 2026 · via day close
Latest settled
+5.07%
T+5 · $4.77
Vs SPY
+1.78%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $4.54entry
  2. T+1 · 11d ago +0.88%α +0.57% · $4.58
  3. T+5 · 5d ago +5.07%α +1.78% · $4.77
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Evolent Health reported Q3 2026 revenue of $725.4M, up 51% YoY, and adjusted EPS of $0.06, in line with consensus of $0.06. The company reiterated full-year revenue guidance of $2.6B-$2.7B and raised its Adjusted EBITDA guidance to $130M-$135M. Revenue growth was driven by strong Performance Suite expansion, but the medical expense ratio deteriorated to 93.0% from 85.0% a year ago, pressuring margins.

Key Financial Metrics

EPS (Adj.)
$0.06
est $0.06 · 0.0% · GAAP: $-0.21
Revenue
$725.4M
est $727.1M · -0.2% · +51.3% YoY
Rating
in line
Guidance
$2.6B-$2.7B
maintained

Key Facts

  • Q3 2026 revenue $725.4M vs $479.5M YoY (+51%)
  • Adjusted EPS $0.06, in line with $0.06 consensus
  • GAAP net loss $23.6M vs $26.9M YoY, loss per share $0.21 vs $0.24
  • Adjusted EBITDA $34.3M vs $39.0M YoY, margin 4.7% vs 8.1%
  • Full-year 2026 revenue guidance reiterated at $2.6B-$2.7B
  • Full-year 2026 Adjusted EBITDA guidance raised to $130M-$135M
  • Medical expense ratio 93.0% vs 85.0% YoY, reflecting higher claims costs
  • Renewed largest Surgical Management customer for 4 years; expanded oncology services with two clients

Financial Impact

Revenue grew 51% YoY to $725.4M; adjusted EBITDA margin compressed from 8.1% to 4.7% due to rising medical costs

revenueadjusted EBITDAmedical expense ratioadjusted EPS

Segment Breakdown

SegmentRevenueGrowth
Performance Suite$564.3M+96.7%
Specialty Technology and Services Suite$72.8M-21.9%
Administrative Services$48.3M-16.5%
Cases$40.0M-3.8%

Risk Factors

  • Medical expense ratio rose to 93.0% from 85.0% YoY, indicating cost pressure
  • Adjusted EBITDA margin declined to 4.7% from 8.1% YoY
  • GAAP net loss continues, though narrowed YoY
  • High dependence on a few large partners for revenue

Market Snapshot

Exchange
NYSE
Sector
Services-Management Services
Analyst Consensus
78% bullish (18 analysts)

Investment Themes

Services

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-prn-302930014

Track record

8 reports on EVH

Performance horizon
Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $4.82 Now $4.83 −0.31% settles Dec 15
  2. Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry $4.74 Now $4.83 −1.90% settles Dec 15
  3. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  4. Nov 5, 202611d ago Press Release Neutral 5/10 Viewing Entry $4.54 Now $4.83 +6.39% settles Dec 4
  5. Aug 6, 202614w ago 8-K Mixed 6/10 Entry $3.59 to $4.26 Now $4.83 +34.54% ▲ +18.66% +18.06% vs SPY
  6. Jul 8, 202618w ago Press Release Neutral 1/10 Entry $5.63 to $3.59 Now $4.83 −14.21% ▼ −36.23% −38.48% vs SPY
  7. Apr 24, 202629w ago DEFA14A Neutral 2/10 Entry $3.47 to $3.83 Now $4.83 +39.19% ▲ +10.37% +5.42% vs SPY
  8. Feb 24, 202637w ago 8-K Mixed 6/10 Entry $3.14 to $2.27 Now $4.83 +53.82% ▼ −27.71% −22.47% vs SPY
Showing 8 of 8

US Market Status

Market Closed · Opens in 8h 50m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026